MedPath

Study using the App for Tinnitus Treatment in Patients with Tinnitus.

Not Applicable
Recruiting
Conditions
Chronic tinnitus with associated suffering
Registration Number
JPRN-jRCTs032230359
Lead Sponsor
Wasano Koichiro
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

1)Outpatients between 18 and 75 years of age at the time of obtaining consent (regardless of gender).
2)Patients with clinically diagnosed chronic unilateral or bilateral tinnitus.
3)Patients who own a smartphone or other device that meets the required OS version (iOS 14.0 or higher, Android 6.0 or higher) and agree to use it for this study.
4)Patients who speak Japanese on a daily basis and determined to have sufficient reading comprehension ability to use the study app by the principal investigator.

Exclusion Criteria

1)Patients with middle ear disease (otitis media, otosclerosis, eustachian tube dysfunction, etc.)or acute hearing loss necessitating treatment.
2)Patients scheduled for or requiring hospitalization or surgical procedures with anesthesia during the study period.
3)Patients with a history of severe psychiatric disorders, (such as severe depression, suicidal ideation, or suicide attempts) or with depression or other psychiatric disorders that are uncontrolled with current medication at certain doses.
4)Patients with clinically significant cardiac, renal, hepatic, vascular, pulmonary, gastrointestinal, endocrine, neurologic, hematology, or metabolic disorders.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in THI total score from week 0 at week 16 after study app prescription.
Secondary Outcome Measures
NameTimeMethod
THI score<br>TFI score<br>NRS score<br>HADS depression score<br>HADS anxiety score<br>AIS score<br>PGI-I score
© Copyright 2025. All Rights Reserved by MedPath